Davis, California
June 7, 2005
AgraQuest, Inc., today
announced the completion of a $14.35 million private round of
financing. The deal was co-led by Otter Capital LLC and new
investors Texas Pacific Group (TPG) and Halcyon Capital. William
E. McGlashan, Jr. of TPG and Payman Pouladdej of Halcyon have
joined the Board of Directors.
“AgraQuest has many exciting opportunities to continue our
global sales expansion and to launch new products in our
pipeline,” said Dr. Mike Miille, AgraQuest’s CEO. “The sizeable
resources and experience of TPG will help create significant
value for our customers and investors.” “We are also grateful
for the continued support of our existing investors who have
helped build the foundation of a company that is now poised for
rapid growth,” added Pam Marrone, the company’s founder.
The
new funds will enable AgraQuest to expand its current products
into additional crops and countries, commercialize new products
in its pipeline, and expand its manufacturing plant. The company
will also use funds for continued development and launch of a
biofumigant product as an alternative to methyl bromide, which
is being phased out because it disrupts the ozone layer.
The
company recently launched Sonata for 14-day mildew control in
fruit, vine and vegetable crops, and Ballad, for prevention of
Asian soybean rust in organic soybeans. In addition, AgraQuest
recently expanded the potential use of its flagship product
Serenade Biofungicide, from 8 crops to over 100 crops including
citrus, peaches and strawberries, and expanded its retail
product line to home gardeners. In 2005, AgraQuest sold Serenade
for the first time in France and Italy, two of the largest
fungicide markets in the world and expects approvals in other
European countries and South Korea later this year.
Several other existing investors participated in the financing,
including Switzerland-based SAM Sustainability Private Equity
LP, Sustainable Performance Group (Unlisted) N.V., and Swiss Re
Investors, Berndt Trusts, JSS Management, Vivo Ventures and
Boldcap Ventures.
AgraQuest is a biotechnology company focused on discovering,
developing, manufacturing and marketing effective, safe and
environmentally friendly natural pest management products for
agricultural, institutional and home markets The company sells
Serenade® and Rhapsody® Biofungicides and recently launched
Sonata® and Ballad® for mildews and rusts on fruit, vegetables
and soybeans. Pending at the EPA are Arabesque™ Biofumigant and
Virtuoso™ Bioinsecticide. In 2003, AgraQuest won the prestigious
Presidential Green Chemistry Award for the discovery and
commercialization of Serenade Biofungicide. In 2004, AgraQuest
received a Red Herring Top 100 Private Company Award and the
World Technology Award for the Environment.
TPG
Ventures was founded in 2001 with $500M of capital and a team of
experts to catalyze the creation of new businesses. Their
investment focus is on early stage and acceleration round
opportunities in information technology and biotechnology — with
an emerging practice in consumer companies. TPG ventures is
affiliated with Texas Pacific Group, a private equity investment
firm with significant investments in many important brand-name
companies including Burger King, Seagate, J.Crew, Bally, and
Ducati. Together with its affiliated partnerships, Texas Pacific
Group has an aggregate committed capital of more than $15.0
billion, with more than $3.0 billion invested in technology and
telecommunications worldwide. |